World's Best Scientists 2026 revealed!
Luca Quartuccio

Luca Quartuccio

D-Index & Metrics

Immunology

D-Index
56
Citations
10902
World Ranking
3727
National Ranking
154

Luca Quartuccio publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Luca Quartuccio sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 379 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Luca Quartuccio D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Luca Quartuccio sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Luca Quartuccio is affiliated with the University of Udine in Italy and has a significant body of research in the medical field, particularly within rheumatology and infectious diseases. Their work spans multiple topics including COVID-19 clinical research, systemic lupus erythematosus, vasculitis, and salivary gland disorders.

Quartuccio's recent publications illustrate a focus on immunological responses and treatment outcomes. Notable recent papers include:

  • "Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care," 2020, Journal of Clinical Virology
  • "COVID 19: a clue from innate immunity," 2020, Immunologic Research

Their research frequently appears in well-established venues, particularly:

  • Annals of the Rheumatic Diseases
  • Clinical and Experimental Rheumatology
  • Lara D. Veeken
  • Rheumatology International
  • Frontiers in Immunology

Quartuccio collaborates regularly with several coauthors, among the most frequent being:

  • Salvatore De Vita
  • Elena Treppo
  • Elena Bartoloni
  • Fabiola Atzeni
  • Franco Franceschini

Their work covers main fields of study such as Medicine, with specific contributions in the subfields of Rheumatology, Physiology, Infectious Diseases, Pulmonary and Respiratory Medicine, and Surgery.

Key topics addressed in their research include:

  • Salivary Gland Disorders and Functions
  • Vasculitis and related conditions
  • Systemic Lupus Erythematosus Research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Sclerosis and Related Diseases

Best Publications

  • A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

    S De Vita;L Quartuccio;M Isola;C Mazzaro

  • Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

    Xavier Mariette;Raphaèle Seror;Luca Quartuccio;Gabriel Baron

  • Primary Sjögren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients

    Chiara Baldini;Pasquale Pepe;Luca Quartuccio;Roberta Priori

  • Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

    Maurizio Pietrogrande;Salvatore De Vita;Anna Linda Zignego;Pietro Pioltelli

  • Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

    Pilar Brito-Zerón;Pilar Brito-Zerón;Nihan Acar-Denizli;Margit Zeher;Astrid Rasmussen

  • Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

    Lorenzo Cavagna;Ernesto Trallero-Araguás;Federica Meloni;Ilaria Cavazzana

  • Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids

    L. Quartuccio;G. Soardo;G. Romano;F. Zaja

  • Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

    Lorenzo Cavagna;Laura Nuño;Carlo Alberto Scirè;Marcello Govoni

  • Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study

    E. Bartoloni;C. Baldini;G. Schillaci;L. Quartuccio

  • BLyS upregulation in Sjögren’s syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands

    Luca Quartuccio;Sara Salvin;Martina Fabris;Marta Maset

  • Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.

    Luca Quartuccio;Miriam Isola;Chiara Baldini;Roberta Priori

  • International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

    Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Chiara Baldini

  • COVID 19: a clue from innate immunity.

    Domenico Birra;Maurizio Benucci;Luigi Landolfi;Anna Merchionda

  • Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care.

    Luca Quartuccio;Arianna Sonaglia;Dennis McGonagle;Martina Fabris

  • Efficacy and safety of belimumab given for 12 months in primary Sjögren’s syndrome: the BELISS open-label phase II study

    Salvatore De Vita;Luca Quartuccio;Raphaèle Seror;Sara Salvin

  • Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study

    Alessandra Bettiol;Maria Letizia Urban;Lorenzo Dagna;Vincent Cottin

  • Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations

    Pilar Brito-Zerón;Elke Theander;Chiara Baldini;Raphaèle Seror

  • B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection

    M. Fabris;L. Quartuccio;S. Sacco;G. De Marchi

  • Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis

    Luca Quartuccio;Martina Fabris;Sara Salvin;Fabiola Atzeni

  • How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).

    Pilar Brito-Zerón;Nihan Acar-Denizli;Wan-Fai Ng;Margit Zeher

  • Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.

    Maria Infantino;Arianna Damiani;Francesca Li Gobbi;Valentina Grossi

  • AB0156 Thymic stromal lymphopoietin (TSLP) in primary sjÖgren's syndrome and related lymphoma: the possible contribution of a novel growth factor

    S Gandolfo;C Fabro;M Bulfoni;S Russi

Frequent Co-Authors

Roberto Gerli
Roberto Gerli University of Perugia
Stefano Bombardieri
Stefano Bombardieri University of Pisa
Roberto Giacomelli
Roberto Giacomelli Campus Bio Medico University Hospital
Alessia Alunno
Alessia Alunno University of L'Aquila
Fabiola Atzeni
Fabiola Atzeni University of Messina
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Guido Valesini
Guido Valesini Sapienza University of Rome
Massimo Galli
Massimo Galli University of Milan
Michele Bombardieri
Michele Bombardieri Queen Mary University of London
Margit Zeher
Margit Zeher University of Debrecen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing a career in immunology with a focus on healthcare, nursing provides several flexible pathways. Many students begin by exploring accelerated nursing programs near me, which offer a fast-track approach to earning a Bachelor of Science in Nursing (BSN). These programs are ideal for learners eager to enter the field quickly without compromising quality.

Non-nurses can also enter the nursing profession through specialized options like online ABSN programs for non nurses. These programs provide the foundational knowledge required to pivot into nursing and subsequently specialize in areas related to immunology and patient care in various healthcare settings.

For those already licensed as Family Nurse Practitioners, further specialization is available. Transitioning via fnp to acute care certification programs allows practitioners to focus on acute and critical care environments, enhancing their expertise in treating complex immunological conditions.

Additionally, accelerated routes such as accelerated FNP programs offer practitioners a faster track to becoming Family Nurse Practitioners, often with online options that fit busy schedules. These pathways collectively support a dynamic career progression for professionals passionate about immunology and patient-centered care.

Best Scientists Citing Luca Quartuccio

Trending Scientists

Recently Published Articles